TCL Archive Cooperative Groups Other Investigators To Get Interferon When Available; DCT Recompetitions Okayed April 4, 1980
TCL Archive In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office November 20, 1992
TCL Archive The Future of Cancer Centers: Demographics Informatics, Genetics, Will BE Major Influences, Robert Young Says May 7, 1999
TCL Archive Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response December 28, 2012
TCL Archive Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors. October 26, 2001
